VANCOUVER, British Columbia, March 19, 2018 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSXV:WML) (OTCQB:WMLLF) (SSE:WMLCL) (Frankfurt:EJZN) announces that it has entered into an agreement (the “Agreement”) with the fully state-owned National Mining Company of Chile (“ENAMI”), whereby the parties have agreed to form a strategic alliance to develop and commercialize…
DetailsGlobeNewswire•March 14, 2018 LOS ANGELES, March 14, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical, (CURR), an innovative drug delivery and development company, today named Steven Ruhl Vice President of Manufacturing. Bringing more than 35 years of experience, Ruhl will oversee all process development and manufacturing operations. “Steven has a proven track record of building and developing…
DetailsPR Newswire•February 26, 2018 LAKEWOOD, CO, Feb. 26, 2018 /PRNewswire/ – Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”), a leading producer of uranium in the United States, is pleased to announce that it has received approval from the U.S. Bureau of Land Management (“BLM”) and U.S. Forest Service (“USFS”) for the expansion of its 100%-owned…
DetailsGlobeNewswire•February 14, 2018 VANCOUVER, British Columbia, Feb. 14, 2018 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (WML.V)(WMLLF)(SSE:WMLCL)(EJZN.F), reports that it has strengthened its board of directors with the appointment of Stefan Schauss to serve as a director. “Mr. Schauss brings to Wealth decades of experience in the electric battery, green power…
DetailsTest Work Demonstrates that Tenova Advanced Technologies’ Process Technology can be Successfully Applied to the Laguna Verde Surface Brines November 16, 2017 08:00 ET VANCOUVER, British Columbia, Nov. 16, 2017 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSX-V:WML) (OTCQB:WMLLF) (SSE:WMLCL) (Frankfurt:EJZN) announces that it has received positive results from its previously…
DetailsCURE Pharmaceutical Adds New VP of Strategy and Business Development January 25, 2018 LOS ANGELES–(BUSINESS WIRE)– CURE Pharmaceutical (OTCQB: CURR) (“CURE”), an innovative drug delivery and development company, today named Dr. Vered Gigi, Vice President of Strategy and Business Development. Dr. Gigi will oversee CURE’s strategy to deliver sustained growth and diversified revenue. “We are…
DetailsOXNARD, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, announced the launch of their new brand initiative, inspired by the company’s mission to support patient needs for better delivery of medication. “Our new branding offers an opportunity to elevate awareness around the challenges patients experience…
DetailsOXNARD, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, will be a presenting company at the 2018 Biotech Showcase in San Francisco, CA, taking place January 8 -10, 2018. “We look forward to sharing how CURE can improve the delivery of pharmaceuticals to improve patient…
Details